{"transactions":[{"id":739060,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T18:37:40.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the \"Plan\") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan)."}],"balance_after":6500,"derivative":{"exercise_price":7.93,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001791742-26-000002","document":"wk-form4_1781289457.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789769/000179174226000002/wk-form4_1781289457.xml","form_type":"4"}},{"id":739582,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":1,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T14:40:06.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the \"Plan\") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan)."}],"balance_after":6500,"derivative":{"exercise_price":7.93,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001402856-26-000003","document":"wk-form4_1781289604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000140285626000003/wk-form4_1781289604.xml","form_type":"4"}},{"id":740114,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38808,"kind":"person","name":"Matcham George","position":1,"cik":"0001851336","reported_name":"Matcham George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T14:38:57.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the \"Plan\") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan)."}],"balance_after":6500,"derivative":{"exercise_price":7.93,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001851336-26-000002","document":"wk-form4_1781289534.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851336/000185133626000002/wk-form4_1781289534.xml","form_type":"4"}},{"id":739240,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38578,"kind":"person","name":"Gibson Neil W","position":1,"cik":"0001555918","reported_name":"Gibson Neil W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T14:38:23.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the \"Plan\") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan)."}],"balance_after":6500,"derivative":{"exercise_price":7.93,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001555918-26-000002","document":"wk-form4_1781289500.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555918/000155591826000002/wk-form4_1781289500.xml","form_type":"4"}},{"id":1041215,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-09-12T21:00:55.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Stock option granted under the Instil Bio, Inc. 2021 Incentive Plan. 25% of the shares subject to the option vested on January 8, 2024 with the remainder vesting in substantially equal monthly tranches thereafter."}],"balance_after":30000,"derivative":{"exercise_price":12.68,"expiration_date":"2033-01-07","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001789769-25-000087","document":"wk-form4_1757710851.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976925000087/wk-form4_1757710851.xml","form_type":"4"}},{"id":1041214,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-09-12T21:00:55.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock option granted under the Instil Bio, Inc. 2021 Incentive Plan. 25% of the shares subject to the option vested on February 10, 2025 with the remainder vesting in substantially equal monthly tranches thereafter."}],"balance_after":17000,"derivative":{"exercise_price":11.6,"expiration_date":"2034-02-09","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001789769-25-000087","document":"wk-form4_1757710851.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976925000087/wk-form4_1757710851.xml","form_type":"4"}},{"id":1041213,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Common Stock","published_at":"2025-09-12T21:00:55.000Z","date":"2025-09-10","kind":"sale","planned":false,"acquired":false,"shares":12461,"price":23.88,"value":297568.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $23.71 to $24.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001789769-25-000087","document":"wk-form4_1757710851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976925000087/wk-form4_1757710851.xml","form_type":"4"}},{"id":1041212,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Common Stock","published_at":"2025-09-12T21:00:55.000Z","date":"2025-09-10","kind":"sale","planned":false,"acquired":false,"shares":17539,"price":23.04,"value":404098.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $22.70 to $23.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."}],"balance_after":12461,"source":{"system":"sec-edgar","filing":"0001789769-25-000087","document":"wk-form4_1757710851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976925000087/wk-form4_1757710851.xml","form_type":"4"}},{"id":1041211,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Common Stock","published_at":"2025-09-12T21:00:55.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":true,"shares":13000,"price":12.68,"value":164840.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001789769-25-000087","document":"wk-form4_1757710851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976925000087/wk-form4_1757710851.xml","form_type":"4"}},{"id":1041210,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Common Stock","published_at":"2025-09-12T21:00:55.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":true,"shares":17000,"price":11.6,"value":197200.0,"ownership":{"direct":true},"balance_after":17000,"source":{"system":"sec-edgar","filing":"0001789769-25-000087","document":"wk-form4_1757710851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976925000087/wk-form4_1757710851.xml","form_type":"4"}},{"id":1130169,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-29T23:13:10.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 substantially equal monthly installments commencing on June 28, 2025, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the \"Plan\") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan)."}],"balance_after":6500,"derivative":{"exercise_price":26.75,"expiration_date":"2035-05-27","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001789769-25-000070","document":"wk-form4_1748560384.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789769/000178976925000070/wk-form4_1748560384.xml","form_type":"4"}},{"id":1130248,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38578,"kind":"person","name":"Gibson Neil W","position":1,"cik":"0001555918","reported_name":"Gibson Neil W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-29T19:12:03.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 substantially equal monthly installments commencing on June 28, 2025, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the \"Plan\") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan)."}],"balance_after":6500,"derivative":{"exercise_price":26.75,"expiration_date":"2035-05-27","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001789769-25-000068","document":"wk-form4_1748560318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555918/000178976925000068/wk-form4_1748560318.xml","form_type":"4"}},{"id":1130663,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38808,"kind":"person","name":"Matcham George","position":1,"cik":"0001851336","reported_name":"Matcham George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-29T19:10:47.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 substantially equal monthly installments commencing on June 28, 2025, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the \"Plan\") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan)."}],"balance_after":6500,"derivative":{"exercise_price":26.75,"expiration_date":"2035-05-27","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001789769-25-000066","document":"wk-form4_1748560241.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851336/000178976925000066/wk-form4_1748560241.xml","form_type":"4"}},{"id":1130427,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":1,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-29T19:09:15.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 substantially equal monthly installments commencing on June 28, 2025, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the \"Plan\") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan)."}],"balance_after":6500,"derivative":{"exercise_price":26.75,"expiration_date":"2035-05-27","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001789769-25-000064","document":"wk-form4_1748560149.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000178976925000064/wk-form4_1748560149.xml","form_type":"4"}},{"id":1164738,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-28T21:00:42.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":44851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on April 25, 2026, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":44851,"derivative":{"exercise_price":12.78,"expiration_date":"2035-04-24","underlying":"Common Stock","underlying_shares":44851},"source":{"system":"sec-edgar","filing":"0001789769-25-000041","document":"wk-form4_1745874035.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976925000041/wk-form4_1745874035.xml","form_type":"4"}},{"id":1164921,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-28T17:00:15.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":105157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on April 25, 2026, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":105157,"derivative":{"exercise_price":12.78,"expiration_date":"2035-04-24","underlying":"Common Stock","underlying_shares":105157},"source":{"system":"sec-edgar","filing":"0001789769-25-000040","document":"wk-form4_1745874009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000178976925000040/wk-form4_1745874009.xml","form_type":"4"}},{"id":1400699,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-23T17:12:01.000Z","date":"2024-09-18","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on September 18, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":45000,"derivative":{"exercise_price":66.1,"expiration_date":"2034-09-17","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001789769-24-000095","document":"wk-form4_1727111515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976924000095/wk-form4_1727111515.xml","form_type":"4"}},{"id":1400955,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-23T13:07:52.000Z","date":"2024-09-18","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on September 18, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":50000,"derivative":{"exercise_price":66.1,"expiration_date":"2034-09-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001789769-24-000093","document":"wk-form4_1727111266.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000178976924000093/wk-form4_1727111266.xml","form_type":"4"}},{"id":1480137,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T21:02:51.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 substantially equal monthly installments commencing on July 13, 2024, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the \"Plan\") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan)."}],"balance_after":5000,"derivative":{"exercise_price":10.5,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001789769-24-000066","document":"wk-form4_1718312563.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789769/000178976924000066/wk-form4_1718312563.xml","form_type":"4"}},{"id":1480855,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38808,"kind":"person","name":"Matcham George","position":1,"cik":"0001851336","reported_name":"Matcham George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T17:03:22.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 substantially equal monthly installments commencing on July 13, 2024, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the \"Plan\") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan)."}],"balance_after":5000,"derivative":{"exercise_price":10.5,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001789769-24-000067","document":"wk-form4_1718312594.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851336/000178976924000067/wk-form4_1718312594.xml","form_type":"4"}},{"id":1480445,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":1,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T17:02:15.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 substantially equal monthly installments commencing on July 13, 2024, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the \"Plan\") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan)."}],"balance_after":5000,"derivative":{"exercise_price":10.5,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001789769-24-000065","document":"wk-form4_1718312526.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000178976924000065/wk-form4_1718312526.xml","form_type":"4"}},{"id":1480255,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38578,"kind":"person","name":"Gibson Neil W","position":1,"cik":"0001555918","reported_name":"Gibson Neil W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T17:01:18.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 substantially equal monthly installments commencing on July 13, 2024, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the \"Plan\") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan)."}],"balance_after":5000,"derivative":{"exercise_price":10.5,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001789769-24-000064","document":"wk-form4_1718312468.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555918/000178976924000064/wk-form4_1718312468.xml","form_type":"4"}},{"id":1645267,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-13T22:40:12.000Z","date":"2024-02-10","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on February 10, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":80000,"derivative":{"exercise_price":11.6,"expiration_date":"2034-02-09","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001789769-24-000025","document":"wk-form4_1707863993.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976924000025/wk-form4_1707863993.xml","form_type":"4"}},{"id":1646496,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-13T17:36:52.000Z","date":"2024-02-10","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on February 10, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":120000,"derivative":{"exercise_price":11.6,"expiration_date":"2034-02-09","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001789769-24-000023","document":"wk-form4_1707863794.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000178976924000023/wk-form4_1707863794.xml","form_type":"4"}},{"id":1681339,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-11T01:10:49.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date."}],"balance_after":1500,"derivative":{"exercise_price":11.18,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001789769-24-000011","document":"wk-form4_1704935440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789769/000178976924000011/wk-form4_1704935440.xml","form_type":"4"}},{"id":1681484,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":1,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-10T19:50:54.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date."}],"balance_after":1500,"derivative":{"exercise_price":11.18,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001789769-24-000010","document":"wk-form4_1704934245.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000178976924000010/wk-form4_1704934245.xml","form_type":"4"}},{"id":1681377,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38578,"kind":"person","name":"Gibson Neil W","position":1,"cik":"0001555918","reported_name":"Gibson Neil W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-10T19:49:39.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date."}],"balance_after":1500,"derivative":{"exercise_price":11.18,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001789769-24-000008","document":"wk-form4_1704934169.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555918/000178976924000008/wk-form4_1704934169.xml","form_type":"4"}},{"id":1681705,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38808,"kind":"person","name":"Matcham George","position":1,"cik":"0001851336","reported_name":"Matcham George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-10T19:49:04.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date."}],"balance_after":1500,"derivative":{"exercise_price":11.18,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001789769-24-000007","document":"wk-form4_1704934135.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851336/000178976924000007/wk-form4_1704934135.xml","form_type":"4"}},{"id":1681346,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":90378,"kind":"person","name":"Nielsen Jack","position":1,"cik":"0001602402","reported_name":"Nielsen Jack","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-10T19:48:01.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date."}],"balance_after":1500,"derivative":{"exercise_price":11.18,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001789769-24-000006","document":"wk-form4_1704934071.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602402/000178976924000006/wk-form4_1704934071.xml","form_type":"4"}},{"id":2049363,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-20T21:10:48.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":234000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":234000,"derivative":{"exercise_price":8.62,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":234000},"source":{"system":"sec-edgar","filing":"0001789769-23-000012","document":"wf-form4a_167424903416782.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976923000012/wf-form4a_167424903416782.xml","form_type":"4/A","original_submission_date":"2022-03-07"}},{"id":2049362,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-20T21:08:03.000Z","date":"2023-01-08","kind":"grant","acquired":true,"shares":415000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on January 8, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":415000,"derivative":{"exercise_price":0.634,"expiration_date":"2033-01-07","underlying":"Common Stock","underlying_shares":415000},"source":{"system":"sec-edgar","filing":"0001789769-23-000008","document":"wf-form4_167424886036425.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976923000008/wf-form4_167424886036425.xml","form_type":"4"}},{"id":2049427,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal and Admin Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-20T21:06:29.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the shares subject to the option vest on January 18, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":50000,"derivative":{"exercise_price":0.7709,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001789769-23-000006","document":"wf-form4_167424877162085.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000178976923000006/wf-form4_167424877162085.xml","form_type":"4"}},{"id":2049426,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":22786,"kind":"person","name":"Ray Sumita","position":1,"cik":"0001579629","reported_name":"Ray Sumita","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal and Admin Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-20T21:06:29.000Z","date":"2023-01-08","kind":"grant","acquired":true,"shares":415000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on January 8, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":415000,"derivative":{"exercise_price":0.634,"expiration_date":"2033-01-07","underlying":"Common Stock","underlying_shares":415000},"source":{"system":"sec-edgar","filing":"0001789769-23-000006","document":"wf-form4_167424877162085.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579629/000178976923000006/wf-form4_167424877162085.xml","form_type":"4"}},{"id":2049835,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-20T16:11:58.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":750000,"derivative":{"exercise_price":8.62,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001789769-23-000014","document":"wf-form4a_167424910228120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000178976923000014/wf-form4a_167424910228120.xml","form_type":"4/A","original_submission_date":"2022-03-07"}},{"id":2049834,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-20T16:09:25.000Z","date":"2023-01-08","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on January 8, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":1000000,"derivative":{"exercise_price":0.634,"expiration_date":"2033-01-07","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001789769-23-000010","document":"wf-form4_167424895139494.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000178976923000010/wf-form4_167424895139494.xml","form_type":"4"}},{"id":2165674,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":64608,"kind":"person","name":"MOORE TIMOTHY L.","position":1,"cik":"0001669207","reported_name":"MOORE TIMOTHY L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-09-06T17:41:36.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on September 6, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":750000,"derivative":{"exercise_price":5.3,"expiration_date":"2032-09-05","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001789769-22-000081","document":"wf-form4_166250048300587.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1669207/000178976922000081/wf-form4_166250048300587.xml","form_type":"4"}},{"id":2256343,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38513,"kind":"person","name":"Binder Gwendolyn","position":1,"cik":"0001791742","reported_name":"Binder Gwendolyn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-05-25T22:01:30.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date."}],"balance_after":30000,"derivative":{"exercise_price":7.27,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001789769-22-000049","document":"wf-form4_165351607627422.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789769/000178976922000049/wf-form4_165351607627422.xml","form_type":"4"}},{"id":2256905,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":111255,"kind":"person","name":"Chiruvolu Vijay","position":1,"cik":"0001851347","reported_name":"Chiruvolu Vijay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-05-25T18:08:05.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":154237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on May 20, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":154237,"derivative":{"exercise_price":7.27,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":154237},"source":{"system":"sec-edgar","filing":"0001789769-22-000055","document":"wf-form4_165351647029928.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851347/000178976922000055/wf-form4_165351647029928.xml","form_type":"4"}},{"id":2256440,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38578,"kind":"person","name":"Gibson Neil W","position":1,"cik":"0001555918","reported_name":"Gibson Neil W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-05-25T18:04:15.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date."}],"balance_after":30000,"derivative":{"exercise_price":7.27,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001789769-22-000053","document":"wf-form4_165351623194991.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555918/000178976922000053/wf-form4_165351623194991.xml","form_type":"4"}},{"id":2256430,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":90378,"kind":"person","name":"Nielsen Jack","position":1,"cik":"0001602402","reported_name":"Nielsen Jack","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-05-25T18:02:45.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date."}],"balance_after":30000,"derivative":{"exercise_price":7.27,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001789769-22-000051","document":"wf-form4_165351614718058.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602402/000178976922000051/wf-form4_165351614718058.xml","form_type":"4"}},{"id":2256569,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":1,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-05-25T17:59:15.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date."}],"balance_after":30000,"derivative":{"exercise_price":7.27,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001789769-22-000047","document":"wf-form4_165351593893691.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000178976922000047/wf-form4_165351593893691.xml","form_type":"4"}},{"id":2256902,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38808,"kind":"person","name":"Matcham George","position":1,"cik":"0001851336","reported_name":"Matcham George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-05-25T17:57:27.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date."}],"balance_after":30000,"derivative":{"exercise_price":7.27,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001789769-22-000045","document":"wf-form4_165351582144757.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851336/000178976922000045/wf-form4_165351582144757.xml","form_type":"4"}},{"id":2327132,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":1,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-17T16:56:19.000Z","date":"2022-03-15","kind":"other","acquired":false,"shares":260323,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The LP distributed these shares to its partners on a pro rata basis, for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held by Ibisbill, LP (the \"LP\"). CPMG, Inc. is the general partner of the LP and has voting and investment control over the shares beneficially owned by the LP. The Reporting Person is the sole shareholder and managing director of CPMG, Inc. and may be deemed to share voting and investment power with respect to the shares beneficially owned by the LP. The Reporting Person disclaims beneficial ownership of the shares beneficially owned by LP except to the extent of any pecuniary interest therein."}],"balance_after":8218467,"source":{"system":"sec-edgar","filing":"0001567619-22-007150","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000156761922007150/doc1.xml","form_type":"4"}},{"id":2348214,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-07T22:10:14.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":245000,"price":8.62,"value":2111900.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":245000,"derivative":{"exercise_price":8.62,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":245000},"source":{"system":"sec-edgar","filing":"0001789769-22-000016","document":"wf-form4_164669099729627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000178976922000016/wf-form4_164669099729627.xml","form_type":"4"}},{"id":2346965,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-07T22:06:40.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":234000,"price":8.62,"value":2017080.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":234000,"derivative":{"exercise_price":8.62,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":234000},"source":{"system":"sec-edgar","filing":"0001789769-22-000013","document":"wf-form4_164669078591142.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976922000013/wf-form4_164669078591142.xml","form_type":"4"}},{"id":2348213,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-07T17:08:31.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":750000,"price":8.62,"value":6465000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":750000,"derivative":{"exercise_price":8.62,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001789769-22-000014","document":"wf-form4_164669088804336.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000178976922000014/wf-form4_164669088804336.xml","form_type":"4"}},{"id":2348220,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":111255,"kind":"person","name":"Chiruvolu Vijay","position":1,"cik":"0001851347","reported_name":"Chiruvolu Vijay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-07T17:05:40.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":257000,"price":8.62,"value":2215340.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":257000,"derivative":{"exercise_price":8.62,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":257000},"source":{"system":"sec-edgar","filing":"0001789769-22-000012","document":"wf-form4_164669070108181.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851347/000178976922000012/wf-form4_164669070108181.xml","form_type":"4"}},{"id":2545626,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-10-08T20:04:40.000Z","date":"2021-10-07","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents performance-based stock option previously granted to the Reporting Person by the Issuer on May 9, 2020. The performance conditions applicable to the award were determined to have been satisfied by the Issuer's Compensation Committee on October 7, 2021, resulting in the immediate vesting of the stock option as to 120,000 shares of Common Stock."}],"balance_after":240000,"derivative":{"exercise_price":0.83,"expiration_date":"2030-05-08","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001789769-21-000063","document":"wf-form4_163372346517423.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000178976921000063/wf-form4_163372346517423.xml","form_type":"4"}},{"id":2572140,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-09-13T22:59:11.000Z","date":"2021-09-10","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents performance-based stock option previously granted to the Reporting Person by the Issuer on May 9, 2020. The performance conditions applicable to the award were determined to have been satisfied by the Issuer's Compensation Committee on September 10, 2021, resulting in the immediate vesting of the stock option as to 120,000 shares of Common Stock."}],"balance_after":120000,"derivative":{"exercise_price":0.83,"expiration_date":"2030-05-08","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001789769-21-000059","document":"wf-form4_163157393793773.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000178976921000059/wf-form4_163157393793773.xml","form_type":"4"}},{"id":2714693,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-13T20:54:09.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in forty-eight (48) equal monthly installments commencing on June 11, 2021, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":200000,"derivative":{"exercise_price":16.25,"expiration_date":"2031-05-10","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001789769-21-000036","document":"wf-form4_162093922749824.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000178976921000036/wf-form4_162093922749824.xml","form_type":"4"}},{"id":2713861,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-13T20:48:05.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in forty-eight (48) equal monthly installments commencing on June 11, 2021, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":200000,"derivative":{"exercise_price":16.25,"expiration_date":"2031-05-10","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001789769-21-000032","document":"wf-form4_162093887102104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976921000032/wf-form4_162093887102104.xml","form_type":"4"}},{"id":2714695,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":111255,"kind":"person","name":"Chiruvolu Vijay","position":1,"cik":"0001851347","reported_name":"Chiruvolu Vijay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-13T16:57:56.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in forty-eight (48) equal monthly installments commencing on June 11, 2021, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":200000,"derivative":{"exercise_price":16.25,"expiration_date":"2031-05-10","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001789769-21-000038","document":"wf-form4_162093944052252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851347/000178976921000038/wf-form4_162093944052252.xml","form_type":"4"}},{"id":2714694,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":111255,"kind":"person","name":"Chiruvolu Vijay","position":1,"cik":"0001851347","reported_name":"Chiruvolu Vijay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-13T16:57:56.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":154237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on April 30, 2022, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":154237,"derivative":{"exercise_price":20.53,"expiration_date":"2031-04-29","underlying":"Common Stock","underlying_shares":154237},"source":{"system":"sec-edgar","filing":"0001789769-21-000038","document":"wf-form4_162093944052252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851347/000178976921000038/wf-form4_162093944052252.xml","form_type":"4"}},{"id":2714692,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-13T16:51:55.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in forty-eight (48) equal monthly installments commencing on June 11, 2021, subject to the Reporting Person continuing to provide service through each such date"}],"balance_after":750000,"derivative":{"exercise_price":16.25,"expiration_date":"2031-05-10","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001789769-21-000034","document":"wf-form4_162093909524987.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000178976921000034/wf-form4_162093909524987.xml","form_type":"4"}},{"id":2771990,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":1948,"kind":"person","name":"Shah Nimish P","position":1,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-03-25T21:31:29.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":400597,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are held by Venrock Healthcare Capital Partners EG, L.P. (\"Partners EG\"). VHCP Management EG, LLC (\"Management EG\") is\nthe sole general partner of Partners EG. The Reporting Person is a voting member of Management EG and may be deemed to share voting and\ninvestment power with respect to the shares held by Partners EG and disclaims Section 16 beneficial ownership of such securities held by\nPartners EG, except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":480716},"source":{"system":"sec-edgar","filing":"0001209191-21-023065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000120919121023065/doc4.xml","form_type":"4"}},{"id":2771989,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":1948,"kind":"person","name":"Shah Nimish P","position":1,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-03-25T21:31:29.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":35861,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by VHCP Co-Investment Holdings III, LLC (\"Holdings III\"). Management III is the manager of Holdings III. The Reporting\nPerson is a voting member of Management III and may be deemed to share voting and investment power with respect to the shares held by\nHoldings III and disclaims Section 16 beneficial ownership of such securities held by Holdings III, except to the extent of his pecuniary interest\ntherein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":43033},"source":{"system":"sec-edgar","filing":"0001209191-21-023065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000120919121023065/doc4.xml","form_type":"4"}},{"id":2771988,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":1948,"kind":"person","name":"Shah Nimish P","position":1,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-03-25T21:31:29.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":358693,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Venrock Healthcare Capital Partners III, L.P. (\"Partners III\"). VHCP Management III, LLC (\"Management III\") is the\nsole general partner of Partners III. The Reporting Person is a voting member of Management III and may be deemed to share voting and\ninvestment power with respect to the shares held by Partners III and disclaims Section 16 beneficial ownership of such securities held by\nPartners III, except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":430431},"source":{"system":"sec-edgar","filing":"0001209191-21-023065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000120919121023065/doc4.xml","form_type":"4"}},{"id":2771987,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":1948,"kind":"person","name":"Shah Nimish P","position":1,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-03-25T21:31:29.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":425025,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by VHCP Co-Investment Holdings III, LLC (\"Holdings III\"). Management III is the manager of Holdings III. The Reporting\nPerson is a voting member of Management III and may be deemed to share voting and investment power with respect to the shares held by\nHoldings III and disclaims Section 16 beneficial ownership of such securities held by Holdings III, except to the extent of his pecuniary interest\ntherein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":510030},"source":{"system":"sec-edgar","filing":"0001209191-21-023065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000120919121023065/doc4.xml","form_type":"4"}},{"id":2771986,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":1948,"kind":"person","name":"Shah Nimish P","position":1,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-03-25T21:31:29.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":4250722,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Venrock Healthcare Capital Partners III, L.P. (\"Partners III\"). VHCP Management III, LLC (\"Management III\") is the\nsole general partner of Partners III. The Reporting Person is a voting member of Management III and may be deemed to share voting and\ninvestment power with respect to the shares held by Partners III and disclaims Section 16 beneficial ownership of such securities held by\nPartners III, except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5100866},"source":{"system":"sec-edgar","filing":"0001209191-21-023065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000120919121023065/doc4.xml","form_type":"4"}},{"id":2771985,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":1948,"kind":"person","name":"Shah Nimish P","position":1,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T21:31:29.000Z","date":"2021-03-23","kind":"purchase","acquired":true,"shares":19620,"price":20,"value":392400.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held by VHCP Co-Investment Holdings II, LLC (\"Holdings II\"). Management II is the manager of Holdings II. The Reporting Person is a voting member of Management II and may be deemed to share voting and investment power with respect to the shares held by Holdings II and disclaims Section 16 beneficial ownership of such securities held by Holdings II, except to the extent of his pecuniary interest therein, if any."}],"balance_after":19620,"source":{"system":"sec-edgar","filing":"0001209191-21-023065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000120919121023065/doc4.xml","form_type":"4"}},{"id":2771984,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":1948,"kind":"person","name":"Shah Nimish P","position":1,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T21:31:29.000Z","date":"2021-03-23","kind":"purchase","acquired":true,"shares":48390,"price":20,"value":967800.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities are held by Venrock Healthcare Capital Partners II, L.P. (\"Partners II\"). VHCP Management II, LLC (\"Management II\") is the sole general partner of Partners II. The Reporting Person is a voting member of Management II and may be deemed to share voting and investment power with respect to the shares held by Partners II and disclaims Section 16 beneficial ownership of such securities held by Partners II, except to the extent of his pecuniary interest therein, if any."}],"balance_after":48390,"source":{"system":"sec-edgar","filing":"0001209191-21-023065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000120919121023065/doc4.xml","form_type":"4"}},{"id":2771983,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":1948,"kind":"person","name":"Shah Nimish P","position":1,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T21:31:29.000Z","date":"2021-03-23","kind":"purchase","acquired":true,"shares":116880,"price":20,"value":2337600.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are held by Venrock Healthcare Capital Partners EG, L.P. (\"Partners EG\"). VHCP Management EG, LLC (\"Management EG\") is\nthe sole general partner of Partners EG. The Reporting Person is a voting member of Management EG and may be deemed to share voting and\ninvestment power with respect to the shares held by Partners EG and disclaims Section 16 beneficial ownership of such securities held by\nPartners EG, except to the extent of his pecuniary interest therein, if any."}],"balance_after":597596,"source":{"system":"sec-edgar","filing":"0001209191-21-023065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000120919121023065/doc4.xml","form_type":"4"}},{"id":2771982,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":1948,"kind":"person","name":"Shah Nimish P","position":1,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T21:31:29.000Z","date":"2021-03-23","kind":"purchase","acquired":true,"shares":10470,"price":20,"value":209400.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by VHCP Co-Investment Holdings III, LLC (\"Holdings III\"). Management III is the manager of Holdings III. The Reporting\nPerson is a voting member of Management III and may be deemed to share voting and investment power with respect to the shares held by\nHoldings III and disclaims Section 16 beneficial ownership of such securities held by Holdings III, except to the extent of his pecuniary interest\ntherein, if any."}],"balance_after":563533,"source":{"system":"sec-edgar","filing":"0001209191-21-023065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000120919121023065/doc4.xml","form_type":"4"}},{"id":2771981,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":1948,"kind":"person","name":"Shah Nimish P","position":1,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T21:31:29.000Z","date":"2021-03-23","kind":"purchase","acquired":true,"shares":104640,"price":20,"value":2092800.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Venrock Healthcare Capital Partners III, L.P. (\"Partners III\"). VHCP Management III, LLC (\"Management III\") is the\nsole general partner of Partners III. The Reporting Person is a voting member of Management III and may be deemed to share voting and\ninvestment power with respect to the shares held by Partners III and disclaims Section 16 beneficial ownership of such securities held by\nPartners III, except to the extent of his pecuniary interest therein, if any."}],"balance_after":5635937,"source":{"system":"sec-edgar","filing":"0001209191-21-023065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000120919121023065/doc4.xml","form_type":"4"}},{"id":2771980,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":1948,"kind":"person","name":"Shah Nimish P","position":1,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T21:31:29.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":480716,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are held by Venrock Healthcare Capital Partners EG, L.P. (\"Partners EG\"). VHCP Management EG, LLC (\"Management EG\") is\nthe sole general partner of Partners EG. The Reporting Person is a voting member of Management EG and may be deemed to share voting and\ninvestment power with respect to the shares held by Partners EG and disclaims Section 16 beneficial ownership of such securities held by\nPartners EG, except to the extent of his pecuniary interest therein, if any."}],"balance_after":480716,"source":{"system":"sec-edgar","filing":"0001209191-21-023065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000120919121023065/doc4.xml","form_type":"4"}},{"id":2771979,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":1948,"kind":"person","name":"Shah Nimish P","position":1,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T21:31:29.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":43033,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by VHCP Co-Investment Holdings III, LLC (\"Holdings III\"). Management III is the manager of Holdings III. The Reporting\nPerson is a voting member of Management III and may be deemed to share voting and investment power with respect to the shares held by\nHoldings III and disclaims Section 16 beneficial ownership of such securities held by Holdings III, except to the extent of his pecuniary interest\ntherein, if any."}],"balance_after":553063,"source":{"system":"sec-edgar","filing":"0001209191-21-023065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000120919121023065/doc4.xml","form_type":"4"}},{"id":2771978,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":1948,"kind":"person","name":"Shah Nimish P","position":1,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T21:31:29.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":430431,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Venrock Healthcare Capital Partners III, L.P. (\"Partners III\"). VHCP Management III, LLC (\"Management III\") is the\nsole general partner of Partners III. The Reporting Person is a voting member of Management III and may be deemed to share voting and\ninvestment power with respect to the shares held by Partners III and disclaims Section 16 beneficial ownership of such securities held by\nPartners III, except to the extent of his pecuniary interest therein, if any."}],"balance_after":5531297,"source":{"system":"sec-edgar","filing":"0001209191-21-023065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000120919121023065/doc4.xml","form_type":"4"}},{"id":2771977,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":1948,"kind":"person","name":"Shah Nimish P","position":1,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T21:31:29.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":510030,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by VHCP Co-Investment Holdings III, LLC (\"Holdings III\"). Management III is the manager of Holdings III. The Reporting\nPerson is a voting member of Management III and may be deemed to share voting and investment power with respect to the shares held by\nHoldings III and disclaims Section 16 beneficial ownership of such securities held by Holdings III, except to the extent of his pecuniary interest\ntherein, if any."}],"balance_after":510030,"source":{"system":"sec-edgar","filing":"0001209191-21-023065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000120919121023065/doc4.xml","form_type":"4"}},{"id":2771976,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":1948,"kind":"person","name":"Shah Nimish P","position":1,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T21:31:29.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":5100866,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common\nStock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Venrock Healthcare Capital Partners III, L.P. (\"Partners III\"). VHCP Management III, LLC (\"Management III\") is the\nsole general partner of Partners III. The Reporting Person is a voting member of Management III and may be deemed to share voting and\ninvestment power with respect to the shares held by Partners III and disclaims Section 16 beneficial ownership of such securities held by\nPartners III, except to the extent of his pecuniary interest therein, if any."}],"balance_after":5100866,"source":{"system":"sec-edgar","filing":"0001209191-21-023065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000120919121023065/doc4.xml","form_type":"4"}},{"id":2771609,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":100686,"kind":"organization","name":"Curative Ventures V LLC","position":1,"cik":"0001754072","reported_name":"Curative Ventures V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-03-25T20:29:41.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":1192729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1431274},"source":{"system":"sec-edgar","filing":"0001209191-21-023011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1754072/000120919121023011/doc4.xml","form_type":"4"}},{"id":2771608,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":100686,"kind":"organization","name":"Curative Ventures V LLC","position":1,"cik":"0001754072","reported_name":"Curative Ventures V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-03-25T20:29:41.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":5082333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6098799},"source":{"system":"sec-edgar","filing":"0001209191-21-023011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1754072/000120919121023011/doc4.xml","form_type":"4"}},{"id":2771607,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":100686,"kind":"organization","name":"Curative Ventures V LLC","position":1,"cik":"0001754072","reported_name":"Curative Ventures V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-03-25T20:29:41.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":25000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":30000000},"source":{"system":"sec-edgar","filing":"0001209191-21-023011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1754072/000120919121023011/doc4.xml","form_type":"4"}},{"id":2771606,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":100686,"kind":"organization","name":"Curative Ventures V LLC","position":1,"cik":"0001754072","reported_name":"Curative Ventures V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T20:29:41.000Z","date":"2021-03-23","kind":"purchase","acquired":true,"shares":450000,"price":20,"value":9000000.0,"ownership":{"direct":true},"balance_after":37980073,"source":{"system":"sec-edgar","filing":"0001209191-21-023011","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1754072/000120919121023011/doc4.xml","form_type":"4"}},{"id":2771605,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":100686,"kind":"organization","name":"Curative Ventures V LLC","position":1,"cik":"0001754072","reported_name":"Curative Ventures V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T20:29:41.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":1431274,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."}],"balance_after":37530073,"source":{"system":"sec-edgar","filing":"0001209191-21-023011","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1754072/000120919121023011/doc4.xml","form_type":"4"}},{"id":2771604,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":100686,"kind":"organization","name":"Curative Ventures V LLC","position":1,"cik":"0001754072","reported_name":"Curative Ventures V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T20:29:41.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":6098799,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."}],"balance_after":36098799,"source":{"system":"sec-edgar","filing":"0001209191-21-023011","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754072/000120919121023011/doc4.xml","form_type":"4"}},{"id":2771603,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":100686,"kind":"organization","name":"Curative Ventures V LLC","position":1,"cik":"0001754072","reported_name":"Curative Ventures V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T20:29:41.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":30000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."}],"balance_after":30000000,"source":{"system":"sec-edgar","filing":"0001209191-21-023011","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754072/000120919121023011/doc4.xml","form_type":"4"}},{"id":2772035,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":110673,"kind":"organization","name":"Vivo Capital IX, LLC","position":1,"cik":"0001750698","reported_name":"Vivo Capital IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110674,"kind":"organization","name":"Vivo Capital Fund IX, L.P.","position":2,"cik":"0001750117","reported_name":"Vivo Capital Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-03-25T17:32:43.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":397576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are held by Vivo Capital Fund IX, L.P. (\"Fund IX\"). Vivo Capital IX, LLC (\"Capital IX\") is the general partner of Fund IX. As the\nmanaging members of Capital IX, Frank Kung, Edgar Engleman, Shan Fu, Hongbo Lu, Mahendra Shah, Jack Nielsen and Michael Chang share\nvoting and dispositive power over the shares held by Fund IX, but each disclaims beneficial ownership of such shares except to the extent of\ntheir individual pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":477091},"source":{"system":"sec-edgar","filing":"0001209191-21-023066","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1750698/000120919121023066/doc4.xml","form_type":"4"}},{"id":2772034,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":110673,"kind":"organization","name":"Vivo Capital IX, LLC","position":1,"cik":"0001750698","reported_name":"Vivo Capital IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110674,"kind":"organization","name":"Vivo Capital Fund IX, L.P.","position":2,"cik":"0001750117","reported_name":"Vivo Capital Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-03-25T17:32:43.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":9758080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are held by Vivo Capital Fund IX, L.P. (\"Fund IX\"). Vivo Capital IX, LLC (\"Capital IX\") is the general partner of Fund IX. As the\nmanaging members of Capital IX, Frank Kung, Edgar Engleman, Shan Fu, Hongbo Lu, Mahendra Shah, Jack Nielsen and Michael Chang share\nvoting and dispositive power over the shares held by Fund IX, but each disclaims beneficial ownership of such shares except to the extent of\ntheir individual pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11709696},"source":{"system":"sec-edgar","filing":"0001209191-21-023066","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1750698/000120919121023066/doc4.xml","form_type":"4"}},{"id":2772033,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":110673,"kind":"organization","name":"Vivo Capital IX, LLC","position":1,"cik":"0001750698","reported_name":"Vivo Capital IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110674,"kind":"organization","name":"Vivo Capital Fund IX, L.P.","position":2,"cik":"0001750117","reported_name":"Vivo Capital Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T17:32:43.000Z","date":"2021-03-23","kind":"purchase","acquired":true,"shares":300000,"price":20,"value":6000000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are held by Vivo Capital Fund IX, L.P. (\"Fund IX\"). Vivo Capital IX, LLC (\"Capital IX\") is the general partner of Fund IX. As the\nmanaging members of Capital IX, Frank Kung, Edgar Engleman, Shan Fu, Hongbo Lu, Mahendra Shah, Jack Nielsen and Michael Chang share\nvoting and dispositive power over the shares held by Fund IX, but each disclaims beneficial ownership of such shares except to the extent of\ntheir individual pecuniary interest therein."}],"balance_after":12486787,"source":{"system":"sec-edgar","filing":"0001209191-21-023066","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1750698/000120919121023066/doc4.xml","form_type":"4"}},{"id":2772032,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":110673,"kind":"organization","name":"Vivo Capital IX, LLC","position":1,"cik":"0001750698","reported_name":"Vivo Capital IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110674,"kind":"organization","name":"Vivo Capital Fund IX, L.P.","position":2,"cik":"0001750117","reported_name":"Vivo Capital Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T17:32:43.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":477091,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are held by Vivo Capital Fund IX, L.P. (\"Fund IX\"). Vivo Capital IX, LLC (\"Capital IX\") is the general partner of Fund IX. As the\nmanaging members of Capital IX, Frank Kung, Edgar Engleman, Shan Fu, Hongbo Lu, Mahendra Shah, Jack Nielsen and Michael Chang share\nvoting and dispositive power over the shares held by Fund IX, but each disclaims beneficial ownership of such shares except to the extent of\ntheir individual pecuniary interest therein."}],"balance_after":12186787,"source":{"system":"sec-edgar","filing":"0001209191-21-023066","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1750698/000120919121023066/doc4.xml","form_type":"4"}},{"id":2772031,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":110673,"kind":"organization","name":"Vivo Capital IX, LLC","position":1,"cik":"0001750698","reported_name":"Vivo Capital IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110674,"kind":"organization","name":"Vivo Capital Fund IX, L.P.","position":2,"cik":"0001750117","reported_name":"Vivo Capital Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T17:32:43.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":11709696,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are held by Vivo Capital Fund IX, L.P. (\"Fund IX\"). Vivo Capital IX, LLC (\"Capital IX\") is the general partner of Fund IX. As the\nmanaging members of Capital IX, Frank Kung, Edgar Engleman, Shan Fu, Hongbo Lu, Mahendra Shah, Jack Nielsen and Michael Chang share\nvoting and dispositive power over the shares held by Fund IX, but each disclaims beneficial ownership of such shares except to the extent of\ntheir individual pecuniary interest therein."}],"balance_after":11709696,"source":{"system":"sec-edgar","filing":"0001209191-21-023066","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1750698/000120919121023066/doc4.xml","form_type":"4"}},{"id":2771646,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":90378,"kind":"person","name":"Nielsen Jack","position":1,"cik":"0001602402","reported_name":"Nielsen Jack","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-03-25T17:30:17.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":397576,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Vivo Capital Fund IX, L.P. (\"Fund IX\"). Vivo Capital IX, LLC (\"Capital IX\") is the general partner of Fund IX. The\nReporting Person is a managing member of Capital IX and may be deemed to share voting and investment power with respect to the shares\nbeneficially owned by Fund IX and disclaims Section 16 beneficial ownership of such securities held by Fund IX, except to the extent of his\npecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":477091},"source":{"system":"sec-edgar","filing":"0001209191-21-023064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1602402/000120919121023064/doc4.xml","form_type":"4"}},{"id":2771645,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":90378,"kind":"person","name":"Nielsen Jack","position":1,"cik":"0001602402","reported_name":"Nielsen Jack","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-03-25T17:30:17.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":9758080,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Vivo Capital Fund IX, L.P. (\"Fund IX\"). Vivo Capital IX, LLC (\"Capital IX\") is the general partner of Fund IX. The\nReporting Person is a managing member of Capital IX and may be deemed to share voting and investment power with respect to the shares\nbeneficially owned by Fund IX and disclaims Section 16 beneficial ownership of such securities held by Fund IX, except to the extent of his\npecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11709696},"source":{"system":"sec-edgar","filing":"0001209191-21-023064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1602402/000120919121023064/doc4.xml","form_type":"4"}},{"id":2771644,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":90378,"kind":"person","name":"Nielsen Jack","position":1,"cik":"0001602402","reported_name":"Nielsen Jack","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T17:30:17.000Z","date":"2021-03-23","kind":"purchase","acquired":true,"shares":300000,"price":20,"value":6000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Vivo Capital Fund IX, L.P. (\"Fund IX\"). Vivo Capital IX, LLC (\"Capital IX\") is the general partner of Fund IX. The\nReporting Person is a managing member of Capital IX and may be deemed to share voting and investment power with respect to the shares\nbeneficially owned by Fund IX and disclaims Section 16 beneficial ownership of such securities held by Fund IX, except to the extent of his\npecuniary interest therein, if any."}],"balance_after":12486787,"source":{"system":"sec-edgar","filing":"0001209191-21-023064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1602402/000120919121023064/doc4.xml","form_type":"4"}},{"id":2771643,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":90378,"kind":"person","name":"Nielsen Jack","position":1,"cik":"0001602402","reported_name":"Nielsen Jack","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T17:30:17.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":477091,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Vivo Capital Fund IX, L.P. (\"Fund IX\"). Vivo Capital IX, LLC (\"Capital IX\") is the general partner of Fund IX. The\nReporting Person is a managing member of Capital IX and may be deemed to share voting and investment power with respect to the shares\nbeneficially owned by Fund IX and disclaims Section 16 beneficial ownership of such securities held by Fund IX, except to the extent of his\npecuniary interest therein, if any."}],"balance_after":12186787,"source":{"system":"sec-edgar","filing":"0001209191-21-023064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1602402/000120919121023064/doc4.xml","form_type":"4"}},{"id":2771642,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":90378,"kind":"person","name":"Nielsen Jack","position":1,"cik":"0001602402","reported_name":"Nielsen Jack","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T17:30:17.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":11709696,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Vivo Capital Fund IX, L.P. (\"Fund IX\"). Vivo Capital IX, LLC (\"Capital IX\") is the general partner of Fund IX. The\nReporting Person is a managing member of Capital IX and may be deemed to share voting and investment power with respect to the shares\nbeneficially owned by Fund IX and disclaims Section 16 beneficial ownership of such securities held by Fund IX, except to the extent of his\npecuniary interest therein, if any."}],"balance_after":11709696,"source":{"system":"sec-edgar","filing":"0001209191-21-023064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1602402/000120919121023064/doc4.xml","form_type":"4"}},{"id":2771812,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":1,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-03-25T17:28:43.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":795152,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Ibisibill, LP (the \"LP\"). CPMG, Inc. is the general partner of the LP and has voting and investment control over the\nshares beneficially owned by the LP. The Reporting Person is the sole shareholder and managing director of CPMG, Inc. and may be deemed to\nshare voting and investment power with respect to the shares beneficially owned by the LP. The Reporting Person disclaims beneficial\nownership of the shares beneficially owned by LP except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":954182},"source":{"system":"sec-edgar","filing":"0001209191-21-023063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000120919121023063/doc4.xml","form_type":"4"}},{"id":2771811,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":1,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-03-25T17:28:43.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":5895507,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Ibisibill, LP (the \"LP\"). CPMG, Inc. is the general partner of the LP and has voting and investment control over the\nshares beneficially owned by the LP. The Reporting Person is the sole shareholder and managing director of CPMG, Inc. and may be deemed to\nshare voting and investment power with respect to the shares beneficially owned by the LP. The Reporting Person disclaims beneficial\nownership of the shares beneficially owned by LP except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7074608},"source":{"system":"sec-edgar","filing":"0001209191-21-023063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000120919121023063/doc4.xml","form_type":"4"}},{"id":2771810,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":1,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T17:28:43.000Z","date":"2021-03-23","kind":"purchase","acquired":true,"shares":450000,"price":20,"value":9000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Ibisibill, LP (the \"LP\"). CPMG, Inc. is the general partner of the LP and has voting and investment control over the\nshares beneficially owned by the LP. The Reporting Person is the sole shareholder and managing director of CPMG, Inc. and may be deemed to\nshare voting and investment power with respect to the shares beneficially owned by the LP. The Reporting Person disclaims beneficial\nownership of the shares beneficially owned by LP except to the extent of any pecuniary interest therein."}],"balance_after":8478790,"source":{"system":"sec-edgar","filing":"0001209191-21-023063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000120919121023063/doc4.xml","form_type":"4"}},{"id":2771809,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":1,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T17:28:43.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":954182,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Ibisibill, LP (the \"LP\"). CPMG, Inc. is the general partner of the LP and has voting and investment control over the\nshares beneficially owned by the LP. The Reporting Person is the sole shareholder and managing director of CPMG, Inc. and may be deemed to\nshare voting and investment power with respect to the shares beneficially owned by the LP. The Reporting Person disclaims beneficial\nownership of the shares beneficially owned by LP except to the extent of any pecuniary interest therein."}],"balance_after":8028790,"source":{"system":"sec-edgar","filing":"0001209191-21-023063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000120919121023063/doc4.xml","form_type":"4"}},{"id":2771808,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":38682,"kind":"person","name":"McGaughy R Kent Jr","position":1,"cik":"0001402856","reported_name":"McGaughy R Kent Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T17:28:43.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":7074608,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Ibisibill, LP (the \"LP\"). CPMG, Inc. is the general partner of the LP and has voting and investment control over the\nshares beneficially owned by the LP. The Reporting Person is the sole shareholder and managing director of CPMG, Inc. and may be deemed to\nshare voting and investment power with respect to the shares beneficially owned by the LP. The Reporting Person disclaims beneficial\nownership of the shares beneficially owned by LP except to the extent of any pecuniary interest therein."}],"balance_after":7074608,"source":{"system":"sec-edgar","filing":"0001209191-21-023063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402856/000120919121023063/doc4.xml","form_type":"4"}},{"id":2772200,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Series C Preferred Stock","published_at":"2021-03-25T16:27:15.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":1192729,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Curative Ventures V LLC (the \"LLC\"). CV-Immetacyte Ultimate Manager LLC (\"Ultimate Manager\") is the general\npartner of CV-Immetacyte Manager LP, the general partner of the LLC. The Reporting Person is the manager of Ultimate Manager and disclaims\nSection 16 beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1431274},"source":{"system":"sec-edgar","filing":"0001209191-21-023006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000120919121023006/doc4.xml","form_type":"4"}},{"id":2772199,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Series B Preferred Stock","published_at":"2021-03-25T16:27:15.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":5082333,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Curative Ventures V LLC (the \"LLC\"). CV-Immetacyte Ultimate Manager LLC (\"Ultimate Manager\") is the general\npartner of CV-Immetacyte Manager LP, the general partner of the LLC. The Reporting Person is the manager of Ultimate Manager and disclaims\nSection 16 beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6098799},"source":{"system":"sec-edgar","filing":"0001209191-21-023006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000120919121023006/doc4.xml","form_type":"4"}},{"id":2772198,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Series A Preferred Stock","published_at":"2021-03-25T16:27:15.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":25000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Curative Ventures V LLC (the \"LLC\"). CV-Immetacyte Ultimate Manager LLC (\"Ultimate Manager\") is the general\npartner of CV-Immetacyte Manager LP, the general partner of the LLC. The Reporting Person is the manager of Ultimate Manager and disclaims\nSection 16 beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":30000000},"source":{"system":"sec-edgar","filing":"0001209191-21-023006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000120919121023006/doc4.xml","form_type":"4"}},{"id":2772197,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-03-25T16:27:15.000Z","date":"2021-03-23","kind":"purchase","acquired":true,"shares":450000,"price":20,"value":9000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Curative Ventures V LLC (the \"LLC\"). CV-Immetacyte Ultimate Manager LLC (\"Ultimate Manager\") is the general\npartner of CV-Immetacyte Manager LP, the general partner of the LLC. The Reporting Person is the manager of Ultimate Manager and disclaims\nSection 16 beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":37980073,"source":{"system":"sec-edgar","filing":"0001209191-21-023006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000120919121023006/doc4.xml","form_type":"4"}},{"id":2772196,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-03-25T16:27:15.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":1431274,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Curative Ventures V LLC (the \"LLC\"). CV-Immetacyte Ultimate Manager LLC (\"Ultimate Manager\") is the general\npartner of CV-Immetacyte Manager LP, the general partner of the LLC. The Reporting Person is the manager of Ultimate Manager and disclaims\nSection 16 beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":37530073,"source":{"system":"sec-edgar","filing":"0001209191-21-023006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000120919121023006/doc4.xml","form_type":"4"}},{"id":2772195,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-03-25T16:27:15.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":6098799,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Curative Ventures V LLC (the \"LLC\"). CV-Immetacyte Ultimate Manager LLC (\"Ultimate Manager\") is the general\npartner of CV-Immetacyte Manager LP, the general partner of the LLC. The Reporting Person is the manager of Ultimate Manager and disclaims\nSection 16 beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":36098799,"source":{"system":"sec-edgar","filing":"0001209191-21-023006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000120919121023006/doc4.xml","form_type":"4"}},{"id":2772194,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":80448,"kind":"person","name":"Crouch Bronson","position":1,"cik":"0001851041","reported_name":"Crouch Bronson","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2021-03-25T16:27:15.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":30000000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Curative Ventures V LLC (the \"LLC\"). CV-Immetacyte Ultimate Manager LLC (\"Ultimate Manager\") is the general\npartner of CV-Immetacyte Manager LP, the general partner of the LLC. The Reporting Person is the manager of Ultimate Manager and disclaims\nSection 16 beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":30000000,"source":{"system":"sec-edgar","filing":"0001209191-21-023006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851041/000120919121023006/doc4.xml","form_type":"4"}},{"id":2776304,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":1948,"kind":"person","name":"Shah Nimish P","position":1,"cik":"0001698082","reported_name":"Shah Nimish P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-23T00:58:12.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 36 equal monthly installments commencing on April 18, 2021, subject to the Report Person's continued service as a director through the vesting date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Reporting Person is a member of VR Management, LLC (the \"Management Company\"). Under an agreement between the Reporting Person and the Management Company, the Reporting Person is deemed to hold the reported shares for the sole benefit of the Management Company and must exercise the reported shares solely upon the direction of the Management Company, which is entitled to the shares. The Management Company may be deemed the indirect beneficial owner of the reported shares, and the Reporting Person may be deemed the indirect beneficial owner of the reported shares through his interest in the Management Company. The Reporting Person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein."}],"balance_after":52000,"derivative":{"exercise_price":20,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001209191-21-022480","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698082/000120919121022480/doc4.xml","form_type":"4"}},{"id":2776424,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":32172,"kind":"person","name":"Roberts Zachary","position":1,"cik":"0001851044","reported_name":"Roberts Zachary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-23T00:57:23.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in forty-eight (48) equal monthly installments commencing on March 19, 2021, subject to the Reporting Person continuing to provide service through each such\ndate."}],"balance_after":240000,"derivative":{"exercise_price":5.95,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001209191-21-022479","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851044/000120919121022479/doc4.xml","form_type":"4"}}],"next_cursor":"2021-03-23T00:57:23.000000Z,2776424"}